semaglutide cardiovascular outcomes news 2025 october protects the heart beyond weight loss, SELECT trial shows Semaglutide and Cardiovascular Outcomes in

In the broader GLP-1 receptor agonist literature, there is growing interest in the relationship between these medicines and hormonal or sexual health

Evidence on the relationship between the two is emerging, but we already have some useful information

In our study, liraglutide prevented the TGF-1 + IL-1-induced augmentation of mitochondrial respiration in fibroblasts, indicating that activating GLP-1R could maintain mitochondrial homeostasis under inflammatory stress

Understanding Melanotan II and How It Works Melanotan II is a synthetic peptide analog of alpha-melanocyte-stimulating hormone (MSH), designed to bind and activate melanocortin receptors